Ten children who were born without functioning immune systems due to Artemis-SCID are now leading healthy lives thanks to a new gene therapy treatment pioneered at UCSF.
In a breakthrough, HT became the first person in the world to receive gene-corrected stem cells for Artemis-SCID. His new immune system is life-changing.
Nineteen-day-old Mason was limp and unresponsive when the transport team got the call to move him to UC Davis Children’s Hospital. The family remembers this difficult night four years later.
Cardiologists recently completed their first transcatheter tricuspid valve replacement (TTVR) procedure, becoming the first hospital in the Sacramento region to perform the minimally invasive treatment.
Through decades of biobanking at UCSF, researchers were able to comprehensively map intra-cellular signaling in the cells of recurrent glioblastoma, identifying novel cell-extrinsic therapeutic targets.
